tirzepatide and cancer 💊 Weight-loss drug shows cancer-fighting potential Researchers at the University of Michigan discovered that (Mounjaro, Zepbound), already FDA-approved for diabetes obesity, also shrinks breast tumors in obese mice. When Weight-loss wonder drug Mounjaro/Zepbound shrinks

A systematic review of over 94,000 adults seeking obesity treatment found that 14% had binge eating disorder on clinical interview and up to 26% reported moderate-to-severe binge eating on self-report measures ( Melville et al., Int J Eating Disorders, 2025 )

However thats not all, along with working as a powerful strobe light, both the tube and the RGB plates can be run continuously for high output blinder and wash light effects, which never reduce output or have thermal cut-out

These medications are FDA-approved for the treatment of obesity, a chronic disease usually characterized by a BMI of 30 or higher

THE INFORMATION BELOW IS PROVIDED SOLELY TO IDENTIFY THE COMPOUND FOR RESEARCH PURPOSES